News

statue justice legal verdict malpractice case lawsuit scale

Children's Wisconsin admitted that it accidentally threw out the brain of a 24-year-old woman who survived a rare childhood illness as a result of a novel gene therapy. A researcher called the organ “irreplaceable.” 

the words "FDA recall" on a board

A model of i-View Video Laryngoscopes manufactured by Intersurgical is defective and will need to be removed from patient care settings and supply houses immediately, as they pose a serious risk to patient health.

business partnership handshake merger acquisition M&A

The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.

Thumbnail

No other heart or transplant services at the nonprofit hospital should be impacted by this temporary shift in care. 

The collaboration allows providers to order diagnostic tests and then receive results directly in Epic.

Much more research is still required, but a new meta-analysis in Stroke suggests these medications may provide valuable stroke prevention.

Caon Medical USA ultrasound director Dan Skyba explains advances in ultrasound processing algorithms at RSNA 2025.

The U.S. Food and Drug Administration has green-lit new updates that improve microvascular flow, AI-assisted harmonic imaging and elastography, which Canon will showcase at RSNA 2025.

breast cancer month ribbon

The Find It Early Act would ensure all women have access to supplemental exams, such as ultrasound and MRI, with no out-of-pocket costs.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

A clinical trial focused on patients with HFpEF is expected to be completed by July 2026.

Boston Scientific ACURATE neo2 aortic valve system self-expanding TAVR valve

Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?

Hexoskin Medical System

According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials. 

Emily Sedgwick 2

The breast screening provider has picked Emily Sedgwick, MD, MBA, to fill the key role and is opening new centers in Texas and Colorado. 

Around the web

Children's Wisconsin admitted that it accidentally threw out the brain of a 24-year-old woman who survived a rare childhood illness as a result of a novel gene therapy. A researcher called the organ “irreplaceable.” 

A model of i-View Video Laryngoscopes manufactured by Intersurgical is defective and will need to be removed from patient care settings and supply houses immediately, as they pose a serious risk to patient health.

The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.